CBD Market
Roundup of latest financial results in the European cannabis space
Get up to date with the latest financial results from Jazz Pharma, Flora Growth, Khiron, MGC Pharma, CBD of Denver and Tilray.
Joe Roberts
84stories
9 Septlast updated
More in Joe Roberts
- Medical
Cannbit-Tikun Olam Israel receives EU-GMP certification
This is the company’s most important strategic move to date, according to CEO Avinoam Sapir
- Medical
Malaysia to consider legalising medical cannabis
A Malaysian official told Reuters that the country wants to “learn from Thailand”.
- Medical
Tilray Medical granted market authorisation in Poland
The company said the approval has bolstered its position in Europe.
- CBD Market
Oli White: from YouTube star to CBD entrepreneur
In his decade-long career in YouTube, Oli White has racked up half a billion views and more than 4 million subscribers.
- Adult-Use
MGC Pharma receives first tranche of funding under new $10m financing facility
The financing facility will fund the execution of MGC Pharma’s business commercialisation strategy in the UK and US.
- Companies
Canopy Growth appoints industry veteran Christelle Gedeon as chief legal officer
Gedeon’s cannabis and commercial expertise will further Canopy Growth’s strategy for North American cannabis leadership, the company said.
- News
Cookies CEO to become first cannabis executive to feature on Forbes front cover
The cover story marks another powerful milestone for the $72 billion cannabis industry.
- Cultivation
Flora Growth partners with Colombia’s largest indigenous tribe in joint cannabis venture
“We are honoured to be given the opportunity to work hand-in-hand with the Misak people,” said Luis Merchan, Flora’s Chairman and CEO.
